Farms.com Home   News

Funding for Alberta under the new federal, provincial, territorial agreement

Alberta will receive $508 million over five years through the new Sustainable Canadian Agricultural Partnership (Sustainable CAP).

The grants will support programs in Alberta’s agriculture and agri-food sector.

Alberta Agriculture and Irrigation Minister Nate Horner said the province’s programs will create new jobs and spur growth in the sector by supporting value-added processing, attracting new investment, and expanding irrigation capacity.

“The new Sustainable CAP provides flexibility to deliver programs that will help producers grow their business and improve productivity while addressing the unique challenges of farming in Alberta,” Horner said in a news release. “Alberta’s producers are among the best in the world when it comes to sustainable practices, and we will continue to support their efforts to feed the world while protecting the environment for generations to come.”

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.